{"id":13342,"date":"2008-11-13T20:00:00","date_gmt":"2008-11-13T20:00:00","guid":{"rendered":""},"modified":"2008-11-13T20:00:00","modified_gmt":"2008-11-13T20:00:00","slug":"kauliu-ciulpu-transplantacija-stabdo-aids-vystymasi-organizme","status":"publish","type":"post","link":"https:\/\/www.pasveik.lt\/lt\/sveikatos-ir-medicinos-naujienos\/kauliu-ciulpu-transplantacija-stabdo-aids-vystymasi-organizme\/13342\/","title":{"rendered":"Kauli\u0173 \u010diulp\u0173 transplantacija stabdo AIDS vystym\u0105si organizme"},"content":{"rendered":"<p class=\"headline\" style=\"margin: 0cm 0cm 0pt; text-align: justify\"><strong><span lang=\"LT\" style=\"font-weight: normal; font-size: 9pt; font-family: Arial; mso-bidi-font-size: 12.0pt; mso-ansi-language: LT\">Vokietijos mokslininkai nustat\u0117, kad naudojant donoro kaul\u0173 \u010diulp\u0173 l\u0105steles ir jas persodinant \u017dIV u\u017esikr\u0117tusiam asmeniui \u012fmanoma pagerinti sergan\u010diojo nat\u016brali\u0105 imuninin\u0119 sistem\u0105. Persodinus donoro kaul\u0173 \u010diulpus \u017dIV infekuotas pacientas neu\u017esikr\u0117t\u0117 jokia papildoma infekcija beveik 3 metus.<o:p><\/o:p><\/span><\/strong><\/p>\n<p class=\"headline\" style=\"margin: 0cm 0cm 0pt; text-align: justify\"><strong><span lang=\"LT\" style=\"font-weight: normal; font-size: 9pt; font-family: Arial; mso-bidi-font-size: 12.0pt; mso-ansi-language: LT\">&nbsp;<o:p><\/o:p><\/span><\/strong><\/p>\n<p class=\"headline\" style=\"margin: 0cm 0cm 0pt; text-align: justify\"><strong><span lang=\"LT\" style=\"font-weight: normal; font-size: 9pt; font-family: Arial; mso-bidi-font-size: 12.0pt; mso-ansi-language: LT\">\u017dIV u\u017esikr\u0117t\u0119s pacientas, gyvenantis Berlyne, taip pat sirgo leukemija, tad jam kaulo \u010diulpai buvo persodinti siekiant gydyti nuo \u0161ios ligos, tuo tarpu atsitiktinai pasteb\u0117ta, kad transplantacija buvo itin naudinga ir stabdant \u017dIV viruso vystym\u0105si. Mokslininkai teigia, kad donoras, kurio kaul\u0173 \u010diulpai buvo persodinti infekuotajam pacientui, turi tam tikr\u0105 kaul\u0173 \u010diulp\u0173 l\u0105steli\u0173 genetin\u0119 mutacij\u0105, kurios d\u0117ka imunin\u0117 sistema tampa itin atspari infekcijoms.<o:p><\/o:p><\/span><\/strong><\/p>\n<p class=\"headline\" style=\"margin: 0cm 0cm 0pt; text-align: justify\"><strong><span lang=\"LT\" style=\"font-weight: normal; font-size: 9pt; font-family: Arial; mso-bidi-font-size: 12.0pt; mso-ansi-language: LT\">&nbsp;<o:p><\/o:p><\/span><\/strong><\/p>\n<p class=\"headline\" style=\"margin: 0cm 0cm 0pt; text-align: justify\"><strong><span lang=\"LT\" style=\"font-weight: normal; font-size: 9pt; font-family: Arial; mso-bidi-font-size: 12.0pt; mso-ansi-language: LT\">Visgi mokslininkai teigia, kad toks \u017dIV viruso gydymas gana pavojingas, kadangi kaul\u0173 \u010diulp\u0173 transplantacija yra itin sud\u0117tinga, o po operacijos paciento k\u016bne turi prad\u0117ti augti naujos kaul\u0173 \u010diulp\u0173 l\u0105stel\u0117s. Kadangi tam reikia laiko,imunin\u0117 sistema b\u016bna silpna, tad \u017dIV virusas gali prad\u0117ti daugintis itin spar\u010diai. <o:p><\/o:p><\/span><\/strong><\/p>\n<p class=\"headline\" style=\"margin: 0cm 0cm 0pt; text-align: justify\"><strong><span lang=\"LT\" style=\"font-weight: normal; font-size: 9pt; font-family: Arial; mso-bidi-font-size: 12.0pt; mso-ansi-language: LT\">&nbsp;<o:p><\/o:p><\/span><\/strong><\/p>\n<p class=\"headline\" style=\"margin: 0cm 0cm 0pt; text-align: justify\"><strong><span lang=\"LT\" style=\"font-weight: normal; font-size: 9pt; font-family: Arial; mso-bidi-font-size: 12.0pt; mso-ansi-language: LT\">Pabr\u0117\u017eiama, kad imunodeficito virusas gydomas \u012fvairiomis vaist\u0173 kombinacijomis ir gali b\u016bti sustabdomas jo plitimas, ta\u010diau, nors kartais paciento organizme tyrimais jo rasti nepavyksta, u\u017esikr\u0117tus jis nebei\u0161nyksta.<o:p><\/o:p><\/span><\/strong><\/p>\n<p class=\"headline\" style=\"margin: 0cm 0cm 0pt; text-align: justify\"><strong><span lang=\"LT\" style=\"font-weight: normal; font-size: 9pt; font-family: Arial; mso-bidi-font-size: 12.0pt; mso-ansi-language: LT\">&nbsp;<o:p><\/o:p><\/span><\/strong><\/p>\n<p class=\"headline\" style=\"margin: 0cm 0cm 0pt; text-align: justify\"><strong><span lang=\"LT\" style=\"font-weight: normal; font-size: 9pt; font-family: Arial; mso-bidi-font-size: 12.0pt; mso-ansi-language: LT\">Ypatinga genetin\u0117 mutacija, kuri\u0105 turintys \u017emon\u0117s gal\u0117t\u0173 b\u016bti kaul\u0173 \u010diulp\u0173 donorais infekuotiesiems yra itin reta. J\u0105 turi tik 3 proc. Europie\u010di\u0173. Visgi, tai gal\u0117t\u0173 b\u016bti genetini\u0173 tyrim\u0173 prad\u017eia, kuri\u0173 rezultatai b\u016bt\u0173 pagrindas tobulesniam \u017dIV gydymui.<o:p><\/o:p><\/span><\/strong><\/p>\n<p class=\"headline\" style=\"margin: 0cm 0cm 0pt; text-align: justify\"><strong><span lang=\"LT\" style=\"font-weight: normal; font-size: 9pt; font-family: Arial; mso-bidi-font-size: 12.0pt; mso-ansi-language: LT\">&nbsp;<o:p><\/o:p><\/span><\/strong><\/p>\n<p><strong><span lang=\"LT\" style=\"font-weight: normal; font-size: 9pt; font-family: Arial; mso-bidi-font-size: 12.0pt; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: LT; mso-fareast-language: EN-US; mso-bidi-language: AR-SA\">Reuters Health<\/span><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p class=\"headline\" style=\"margin: 0cm 0cm 0pt; text-align: justify\"><strong><span lang=\"LT\" style=\"font-weight: normal; font-size: 9pt; font-family: Arial; mso-bidi-font-size: 12.0pt; mso-ansi-language: LT\">Vokietijos mokslininkai nustat\u0117, kad naudojant donoro kaul\u0173 \u010diulp\u0173 l\u0105steles ir jas persodinant \u017dIV u\u017esikr\u0117tusiam asmeniui \u012fmanoma pagerinti sergan\u010diojo nat\u016brali\u0105 imuninin\u0119 sistem\u0105. Persodinus donoro kaul\u0173 \u010diulpus \u017dIV infekuotas pacientas neu\u017esikr\u0117t\u0117 jokia papildoma infekcija beveik 3 metus.<o:p><\/o:p><\/span><\/strong><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[],"tags":[910,8,132],"site":[],"post_item_type":[27344],"class_list":["post-13342","post","type-post","status-publish","format-standard","hentry","tag-ciulpai","tag-virusas","tag-ziv"],"acf":{"post_sites":false},"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/posts\/13342","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/comments?post=13342"}],"version-history":[{"count":0,"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/posts\/13342\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/media?parent=13342"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/categories?post=13342"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/tags?post=13342"},{"taxonomy":"site","embeddable":true,"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/site?post=13342"},{"taxonomy":"post_item_type","embeddable":true,"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/post_item_type?post=13342"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}